RFS by prior treatment status and treatment arm
| . | Relapsed/refractory patients (N = 68) . | Previously untreated patients (N = 14) . | ||||||
|---|---|---|---|---|---|---|---|---|
| RFS at 2 y (%) . | 95% CI . | RR . | 95% CI . | RFS at 2 y (%) . | 95% CI . | RR . | 95% CI . | |
| Control | 10 | 0 -21 | 1.00 | — | 5 | 0 -52 | 1.00 | — |
| CsA | 28 | 14 -43 | 0.67 | 0.39 -1.15 | 60 | 24 -96 | 0.20 | 0.05 -0.84 |
| . | Relapsed/refractory patients (N = 68) . | Previously untreated patients (N = 14) . | ||||||
|---|---|---|---|---|---|---|---|---|
| RFS at 2 y (%) . | 95% CI . | RR . | 95% CI . | RFS at 2 y (%) . | 95% CI . | RR . | 95% CI . | |
| Control | 10 | 0 -21 | 1.00 | — | 5 | 0 -52 | 1.00 | — |
| CsA | 28 | 14 -43 | 0.67 | 0.39 -1.15 | 60 | 24 -96 | 0.20 | 0.05 -0.84 |